Manufacturing problems persist for Aurobindo, U.S.’ second-largest generics producer
Mylan and Hospira both recall injected drugs after particulate discovered in vials
Thermo Fisher expands biologics manufacturing at 3 sites
FDA hits United Exchange with warning letter, citing poor quality control
Merck KGaA investing €1B at headquarters site as part of 5-year work agreement
